Brinzolamide: all 39 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both EyesCompletedNCT04024072Phase 3Results posted
• Therapeutic Equivalence Study of Generic Brinzolamide vs AzoptCompletedNCT03896633Phase 1/2Results posted
• Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension GlaucomaCompletedNCT03150160Phase 4Results posted
• 24-hr Intraocular Pressure Control With SIMBRINZA ®CompletedNCT02770248Phase 4Results posted
• Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®TerminatedNCT02730871Phase 4Results posted
• SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)CompletedNCT02419508Phase 4Results posted
• Stop Retinal Ganglion Cell Dysfunction StudyTerminatedNCT02390284Phase 3Results posted
• Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)CompletedNCT02339584Phase 3Results posted
• Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic SolutionCompletedNCT02325518Phase 4Results posted
• Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01978600Phase 4Results posted
• Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin AnalogueCompletedNCT01937312Phase 4Results posted
• Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®CompletedNCT01937299Phase 4Results posted
• Therapeutic Equivalence Study of Generic Brinzolamide vs AzoptCompletedNCT01722604Phase 3Results posted
• AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular PressureCompletedNCT01484951Phase 4Results posted
• A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%CompletedNCT01426867Phase 2Results posted
• Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in CanadaCompletedNCT01415401Phase 4Results posted
• Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01357616Phase 3Results posted
• Patient Preference Comparison of AZARGA Versus COSOPTCompletedNCT01340014Phase 4Results posted
• Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01310777Phase 3Results posted
• Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01309204Phase 3Results posted
• Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%CompletedNCT01297920Phase 3Results posted
• Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%CompletedNCT01297517Phase 3Results posted
• Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin TherapyCompletedNCT01263444Phase 4Results posted
• Safety and Efficacy of Brinzolamide/Brimonidine Fixed CombinationTerminatedNCT00961649Phase 2Results posted
• Circadian Ocular Perfusion Pressure and Ocular Blood FlowCompletedNCT00800540Phase 4Results posted
• A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a ProstaglandinCompletedNCT00759941Phase 4Results posted
• Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus SyndromeCompletedNCT01312402Phase 4
• 1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPTTerminatedNCT00767481Phase 3
• Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT00761995Phase 4
• Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin AnalogsCompletedNCT00675207Phase 4
• IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00527501Phase 2
• IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive TherapyCompletedNCT00382226Phase 4
• Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular HypertensionCompletedNCT00372827Phase 4
• A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00326092Phase 2
• A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00314171Phase 3
• A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00314158Phase 3
• Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular HypertensionCompletedNCT00300079Phase 4
• Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to TravatanCompletedNCT00121147Not applicable
• Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular HypertensionCompletedNCT00061516Phase 3

← Brinzolamide overview